HE8CS41 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing HE8CS41 polypeptides and polynucleotides in the design of protocols fo r the treatment of infections such as bacterial, fungal, protozoan and viral infection s, particularly infections caused by HIV-1 or HIV-2; pain; cancers; anorexia; bulimia; asthma; P arkinson's disease; acute heart failure; hypotension; hypertension, urinary retention; oste oporosis; angina pectoris; myocardial infarction; ulcers; asthma; allergies; benign prostatic hyp ertrophy; and psychotic and neurological disorders, including anxiety, schizophrenia, manic de pression delirium, dementia, severe mental retardation and dyskinesias, such as Huntington's diseas e or Gilles dela Tourett's syndrome, among others and diagnostic assays for such conditions.
CDNA CLONE HE8CS41 THAT ENCODES A NOVEL 7-TRANSMEMBRANE RECEPTOR